In newborn AD transgenic mouse models, knockdown of GSK3α and GSK3β reduces tau phosphorylation and tau misfolding, while the knockdown of GSK3α, but not GSK3β, leads to reduced senile plaques formation. This evidence concerns the gene GSK3A and Alzheimer disease.